Fig. 1: shRNA knockdown of endogenous VMAT2 in rat substantia nigra in vivo. | npj Parkinson's Disease

Fig. 1: shRNA knockdown of endogenous VMAT2 in rat substantia nigra in vivo.

From: Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease

Fig. 1

a Representative image following unilateral AAV2-shVMAT2 injection to the substantia nigra (SN) demonstrating viral transduction, identified by GFP expression (green), and a loss of VMAT2 protein (purple) within TH-positive (blue) neurons. b 90x magnification confocal images of transduced TH-positive neurons in the SN following unilateral AAV2-shControl (top) and AAV2-shVMAT2 (bottom) with corresponding nontransduced contralateral hemispheres. c Quantification of VMAT2 immunoreactivity within AAV2-shControl and AAV2-shVMAT2 transduced TH-positive neurons expressed as a percentage of the immunoreactivity from internal control nontransduced TH-positive neurons in the contralateral hemisphere (unpaired t-test, n = 5 animals per treatment group, p = 0.0005). Each data point represents the average value for an individual animal calculated from at least 100 neurons per animal. d Quantification of TH immunoreactivity within AAV2-shControl and AAV2-shVMAT2 transduced TH-positive neurons expressed as a percentage of the immunoreactivity from internal control TH-positive neurons in the nontransduced contralateral hemisphere. (unpaired t-test, n = 5 animals, n.s.) Each data point represents the average value for an individual animal calculated from at least 100 neurons per animal. Error bars represent mean and standard error of the mean.

Back to article page